Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.50 |
| ▸ | FDPS | P14324 | 2/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11154564 | 1.00 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL28398962 | 1.00 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL8368601 | 0.97 | FDPS (0.48) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL22720561 | 0.89 | — | — | |
| Thiourea SCHEMBL10617827 | 0.89 | SMPD1 (0.47) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL49451 | 0.86 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL3889751 | 0.86 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL7708250 | 0.86 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL11518073 | 0.86 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 | |
| SCHEMBL11405905 | 0.86 | SMPD1 (0.50) | SMPD1FDPSDNM1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1719794-B1 | NOVEL POLYMERS AND USES THEREOF | MITSUI CHEMICALS INC (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-7977429-B2 | Polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20070154431-A1 | Novel polymers and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2007-07-05 | — | — | US | disclosed |
| EP-1719794-A1 | NOVEL POLYMERS AND USES THEREOF | Mitsui Takeda Chemicals, Inc. (JP) | 2006-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154431-A1 | Novel polymers and uses thereof | RAD54L, VCL, TYR | SMPD1 3919/4885FDPS 4258/4885DNM1 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.